Resilia Pharmaceuticals
Location
50 Glenlake Parkway, Suite 450,
Atlanta, 30328, GA,
United States
Website
https://www.resiliapharma.com/
Phone
1 888-998-0770
Artw industry
Life Sciences
Employee
Revenue

Resilia Pharmaceuticals Technographics

Resilia Pharmaceuticals Software Purchases and Digital Transformation Initiatives

Discover the latest software purchases and digital transformation initiatives being undertaken by Resilia Pharmaceuticals and its business and technology executives. Each quarter our research team identifies on-prem and cloud applications that are being used by the 35 Resilia Pharmaceuticals employees from the public (Press Releases, Customer References, Testimonials, Case Studies and Success Stories) and proprietary sources.

During our research, we have identified that Resilia Pharmaceuticals has purchased the following applications: Synergistix CATS Software Suite for Life Sciences CRM in 2023 and the related IT decision-makers and key stakeholders.

Our database provides customer insight and contextual information on which enterprise applications and software systems Resilia Pharmaceuticals is running and its propensity to invest more and deepen its relationship with Synergistix or identify new suppliers as part of their overall Digital and IT transformation projects to stay competitive, fend off threats from disruptive forces, or comply with internal mandates to improve overall enterprise efficiency.

We have been analyzing Resilia Pharmaceuticals revenues, which have grown to $10.0 million in 2024, plus its IT budget and roadmap, cloud software purchases, aggregating massive amounts of data points that form the basis of our forecast assumptions for Resilia Pharmaceuticals intention to invest in emerging technologies such as AI, Machine Learning, IoT, Blockchain, Autonomous Database or in cloud-based ERP, HCM, CRM, EPM, Procurement or Treasury applications.

Resilia Pharmaceuticals Data, Technology Stack, and Enterprise Applications
CRM
Vendor
Old Product
New Product
Category
Market
VAR/SI
When
Live
Synergistix Legacy Synergistix CATS Software Suite Life Sciences CRM CRM n/a 2023 2023
IT Decision Makers and Key Stakeholders at Resilia Pharmaceuticals
First Name Last Name Title Function Department Email Phone
No data found
Show All Contacts
Apps Being Evaluated by Resilia Pharmaceuticals Executives
Date Company Status Vendor Product Category Market
No data found
FAQ - APPS RUN THE WORLD Resilia Pharmaceuticals Technographics

Resilia Pharmaceuticals is a Life Sciences organization based in United States, with around 35 employees and annual revenues of $10.0 million.

Resilia Pharmaceuticals operates a diverse technology stack with applications such as Synergistix CATS Software Suite, covering areas like Life Sciences CRM.

Resilia Pharmaceuticals has invested in cloud applications and AI-driven platforms to optimize efficiency and growth, collaborating with vendors such as Synergistix.

Resilia Pharmaceuticals recently adopted applications including Synergistix CATS Software Suite in 2023, highlighting its ongoing modernization strategy.

APPS RUN THE WORLD maintains an up-to-date database of Resilia Pharmaceuticals’s key decision makers and IT executives, available to Premium subscribers.

Our research team continuously updates Resilia Pharmaceuticals’s profile with verified software purchases, vendor relationships, and digital initiatives identified from public and proprietary sources.

Subscribe to APPS RUN THE WORLD to access the complete Resilia Pharmaceuticals technographics profile, including detailed breakdowns by category, vendor, and IT decision makers.